Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Oil-Dri
ODC
$1.28B
| $9.29M | 0.01% |
606,092
-15,196
| -2% | -$199K |
|
1152
Integra LifeSciences
IART
$1.35B
| $9.23M | 0.01% |
170,860
+10,400
| +6% | +$625K |
|
1153
Marcus & Millichap
MMI
$1.18B
| $9.2M | 0.01% |
248,700
+190,700
| +329% | +$8.29M |
|
1154
HCI Group
HCI
$2.28B
| $9.14M | 0.01% |
134,926
+14,907
| +12% | +$985K |
|
|
PDM
1155
Piedmont Realty Trust
PDM
$1.19B
| $9.13M | 0.01% |
695,700
+382,600
| +122% | +$5.76M |
|
1156
Graham Holdings Company
GHC
$5.03B
| $9.13M | 0.01% |
16,098
-4,100
| -20% | -$2.44M |
|
1157
First Busey Corp
BUSE
$2.58B
| $9.12M | 0.01% |
399,139
+1,900
| +0.5% | +$44.1K |
|
1158
iShares US Real Estate ETF
IYR
$4.52B
| $9.11M | 0.01% |
99,000
-6,100
| -6% | -$608K |
|
1159
G. Willi-Food International
WILC
$385M
| $9.1M | 0.01% |
577,752
-7,540
| -1% | -$127K |
|
1160
Delek US
DK
$4.12B
| $9.08M | 0.01% |
351,369
+277,569
| +376% | +$7.49M |
|
1161
Tandem Diabetes Care
TNDM
$1.63B
| $9.07M | 0.01% |
153,227
+131,327
| +600% | +$10.8M |
|
1162
Frontline
FRO
$8.81B
| $9.06M | 0.01% |
1,018,386
+696,057
| +216% | +$6.3M |
|
1163
Diamondrock Hospitality Co
DRH
$2.5B
| $9.05M | 0.01% |
1,102,329
+744,829
| +208% | +$7.26M |
|
1164
First Majestic Silver
AG
$9.44B
| $9.01M | 0.01% |
+1,254,138
| New | +$12.2M |
|
|
SCPL
1165
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $8.99M | 0.01% |
643,700
+62,900
| +11% | +$839K |
|
1166
ResMed
RMD
$32.8B
| $8.96M | 0.01% |
42,648
+21,913
| +106% | +$4.67M |
|
|
FFNW
1167
DELISTED
First Financial Northwest, Inc
FFNW
| $8.94M | 0.01% |
575,008
-9,969
| -2% | -$165K |
|
1168
Portland General Electric
POR
$5.74B
| $8.93M | 0.01% |
184,765
+72,600
| +65% | +$3.61M |
|
|
KNBE
1169
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $8.92M | 0.01% |
571,100
+335,000
| +142% | +$6.55M |
|
1170
Donegal Group Class A
DGICA
$692M
| $8.91M | 0.01% |
522,711
-35,900
| -6% | -$538K |
|
1171
Lakeland Industries
LAKE
$119M
| $8.9M | 0.01% |
579,602
+1,800
| +0.3% | +$30.6K |
|
1172
Hims & Hers Health
HIMS
$6.99B
| $8.88M | 0.01% |
1,959,100
+276,500
| +16% | +$1.18M |
|
1173
ProShares UltraPro Short QQQ
SQQQ
$1.73B
| $8.85M | 0.01% |
+6,015
| New | +$7.44M |
|
|
MCBC
1174
DELISTED
Macatawa Bank Corp
MCBC
| $8.83M | 0.01% |
999,217
-81,564
| -8% | -$728K |
|
1175
Belden
BDC
$5.39B
| $8.82M | 0.01% |
165,563
+69,000
| +71% | +$3.69M |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.